BML Capital Management

BML Capital Management as of June 30, 2026

Portfolio Holdings for BML Capital Management

BML Capital Management holds 18 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Aclaris Therapeutics (ACRS) 36.0 $63M 12M 5.29
Atea Pharmaceuticals (AVIR) 18.4 $32M 7.0M 4.65
Engene Therapeutics Com *a* (ENGN) 6.6 $12M 6.7M 1.73
Kraft Heinz (KHC) 6.2 $11M 465k 23.62
Outset Med Com New (OM) 6.2 $11M 2.5M 4.32
CarMax (KMX) 5.2 $9.1M 173k 52.89
Tillys Cl A (TLYS) 5.1 $9.0M 2.2M 4.20
Pmv Pharmaceuticals (PMVP) 4.1 $7.1M 5.3M 1.34
Instil Bio Com New (TIL) 2.8 $5.0M 646k 7.69
Target Corporation (TGT) 2.8 $4.9M 38k 130.61
Oramed Pharmaceuticals Com New (ORMP) 2.4 $4.2M 866k 4.81
Janux Therapeutics (JANX) 1.4 $2.4M 155k 15.36
Pliant Therapeutics (PLRX) 1.0 $1.8M 1.5M 1.14
Connect Biopharma Hldgs SHS (CNTB) 0.8 $1.4M 573k 2.38
Imagenebio (IMA) 0.7 $1.2M 201k 5.90
Wal-Mart Stores Put Option (WMT) 0.2 $386k 335.00 1152.50
Core Scientific Put Option (CORZ) 0.2 $298k 800.00 372.50
Tesla Motors Put Option (TSLA) 0.2 $270k 375.00 720.00